Literature DB >> 9816133

Prediction of occult neck metastases in laryngeal carcinoma: role of proliferating cell nuclear antigen, MIB-1, and E-cadherin immunohistochemical determination.

A Franchi1, O Gallo, V Boddi, M Santucci.   

Abstract

The aim of this study is to investigate the predictive value of proliferative activity assessment and E-cadherin expression by means of immunohistochemistry in identifying patients with laryngeal squamous cell carcinoma at a high risk for occult node metastasis. Thirty consecutive patients treated for laryngeal carcinoma with false clinically negative nodes (occult metastases, pN+) between the years 1980 and 1990 were selected for this study. A group of 30 cases with negative cervical lymph nodes (pN-) having a similar anatomic site and tumor size distribution was used as control. In each case, several histological parameters, including grade, pattern of invasion, number of mitosis (x10 high-power field), tumor inflammatory infiltrate, and tumor sclerosis, were assessed. Proliferative activity was determined using immunohistochemical staining for proliferating cell nuclear antigen (PCNA) and MIB-1. Other putative prognostic factors investigated at the immunohistochemical level were the cell adhesion molecule E-cadherin and two oncoproteins, p53 and c-erbB-2. In pN+ cases, the expression of PCNA and MIB-1 was significantly higher than in the pN- group. Moreover, a significant loss of E-cadherin expression was observed in carcinomas with occult metastases. No differences in p53 and c-erbB-2 oncoproteins were found between pN+ and pN- cases. Among the other pathological parameters examined, only histological grade was significantly associated with the presence of occult metastases, but on multivariate analysis, this relationship was lost. We conclude that PCNA, MIB-1, and E-cadherin are independent predictors of occult nodal disease in laryngeal squamous cell carcinoma, and their immunohistochemical determination could be useful in identifying patients with clinically negative lymph nodes who are at considerable risk for occult metastases and who may benefit from elective neck dissection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9816133

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  11 in total

1.  Lack of association of cadherin expression and histopathologic type, metastasis, or patient outcome in oropharyngeal squamous cell carcinoma: a tissue microarray study.

Authors:  O C Ukpo; W L Thorstad; Q Zhang; J S Lewis
Journal:  Head Neck Pathol       Date:  2011-11-10

Review 2.  Nasopharyngeal carcinoma--review of the molecular mechanisms of tumorigenesis.

Authors:  Josephine Chou; Yu-Ching Lin; Jae Kim; Liang You; Zhidong Xu; Biao He; David M Jablons
Journal:  Head Neck       Date:  2008-07       Impact factor: 3.147

3.  CCND1 amplification and cyclin D1 immunohistochemical expression in head and neck squamous cell carcinomas.

Authors:  Henning Hanken; Alexander Gröbe; Georg Cachovan; Ralf Smeets; Ronald Simon; Guido Sauter; Max Heiland; Marco Blessmann
Journal:  Clin Oral Investig       Date:  2013-03-15       Impact factor: 3.573

Review 4.  Predictive factors of neck metastases in laryngeal squamous cell carcinoma. Towards an integrated clinico-molecular classification.

Authors:  G Almadori; F Bussu; G Paludettii
Journal:  Acta Otorhinolaryngol Ital       Date:  2006-12       Impact factor: 2.124

5.  The cadherin-catenin complex in nasopharyngeal carcinoma.

Authors:  H Galera-Ruiz; M J Ríos; R González-Cámpora; M de Miguel; M I Carmona; A M Moreno; Hugo Galera-Davidson
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-01-15       Impact factor: 2.503

6.  Preliminary results of prognostic significance of proliferating cell nuclear antigen expression in advanced primary larynx carcinomas and lymph node metastases.

Authors:  Krzysztof Kupisz; Andrzej Stepulak; Małgorzata Zdunek; Janusz Klatka
Journal:  Arch Med Sci       Date:  2010-03-09       Impact factor: 3.318

7.  The cadherin-catenin complex in laryngeal squamous cell carcinoma.

Authors:  H Galera-Ruiz; M J Ríos-Moreno; R González-Cámpora; I Ortega; A Fernández; A García-Escudero; H Galera-Davidson
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-12-25       Impact factor: 2.503

8.  Loss of Heterozygosities in Five Tumor Suppressor Genes (FHIT Gene, p16, pRb, E-Cadherin and p53) in Thyroid Tumors.

Authors:  Jin Hwan Kim; Kyu Young Choi; Dong Jin Lee; Young-Soo Rho; Sung-Jin Jo
Journal:  Clin Exp Otorhinolaryngol       Date:  2014-02-05       Impact factor: 3.372

Review 9.  Transcription regulation of E-cadherin by zinc finger E-box binding homeobox proteins in solid tumors.

Authors:  Thian-Sze Wong; Wei Gao; Jimmy Yu-Wai Chan
Journal:  Biomed Res Int       Date:  2014-08-13       Impact factor: 3.411

10.  The role of E-cadherin and β-catenin in laryngeal cancer.

Authors:  Carlos Eduardo Nardi; Rogério Aparecido Dedivitis; Ricardo Camillo de Almeida; Leandro Luongo de Matos; Claudio Roberto Cernea
Journal:  Oncotarget       Date:  2018-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.